Exo Therapeutics
Wanda Manieri has a strong background in protein biochemistry and biophysics. Wanda started their career at Constellation Pharmaceuticals in 2011 as a Scientist, focusing on protein biochemistry. Wanda worked in this role until December 2015. In 2016, they joined Vertex Pharmaceuticals, where they specialized in protein science and biochemistry. Wanda held this position until April 2021. Currently, Wanda works at Exo Therapeutics as a Principal Scientist in protein biochemistry and biophysics, a position they have held since May 2021.
Wanda Manieri holds a PhD degree in Protein Biochemistry from the University of Neuchatel in Switzerland. No specific details about the duration or year of completion have been provided.
This person is not in the org chart
This person is not in any teams
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential toreprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.